SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-053488
Filing Date
2018-10-11
Accepted
2018-10-11 16:41:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 tv504684_sc13ga.htm SC 13G/A 42416
  Complete submission text file 0001144204-18-053488.txt   44104
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46247 | Film No.: 181118690
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address LEVEL 12, INTERNATIONAL COMMERCE CENTRE 1 AUSTIN ROAD WEST HONG KONG K3 HK
Business Address LEVEL 12, INTERNATIONAL COMMERCE CENTRE 1 AUSTIN ROAD WEST HONG KONG K3 HK 36698324
Wealth Strategy Holding Ltd (Filed by) CIK: 0001723544 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 0331
Type: SC 13G/A